ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Psychiatry

Top Psychiatry Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JENNIFER FYLER

Psychiatry

361

$35.6K

45
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

31%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 26%

$99
Average prescription price

Avg: $146

HOLLIDAY RAYFIELD M.D.

Psychiatry

366

$34.9K

35
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 26%

$95
Average prescription price

Avg: $146

HANNAH POWELL MD.

Psychiatry

392

$42.9K

23
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $146

LOREN LANDIS M.D.

Psychiatry

516

$124K

19
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

58%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 26%

$241
Average prescription price

Avg: $146

JAMES JACOBSON M.D.

Psychiatry

519

$67.9K

22
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$131
Average prescription price

Avg: $146

STUART GRAVES MD

Psychiatry

595

$74K

53
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$124
Average prescription price

Avg: $146

SABA SALAM MD

Psychiatry

606

$54.5K

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$90
Average prescription price

Avg: $146

NEIL SENIOR M.D.

Psychiatry

625

$130K

44
0 are 65+

50%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$209
Average prescription price

Avg: $146

SHANA BERGER MD

Psychiatry

637

$83.9K

96
16 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$132
Average prescription price

Avg: $146

ANDREW STOLL MD

Psychiatry

651

$71.2K

31
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $146

GARY KELLER M.D.

Psychiatry

669

$59.6K

39
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$89
Average prescription price

Avg: $146

SUSAN LEGACY MD

Psychiatry

723

$109K

39
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$151
Average prescription price

Avg: $146

DAVID MOONEY MD

Psychiatry

885

$140K

78
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$159
Average prescription price

Avg: $146

ROBERT JIMERSON M.D.

Psychiatry

997

$126K

65
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 26%

$127
Average prescription price

Avg: $146

BEATRICE JOHNSON MD

Psychiatry

1,112

$131K

68
0 are 65+

21%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$117
Average prescription price

Avg: $146

JENNIFER CONNORS MD

Psychiatry

1,123

$154K

101
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$137
Average prescription price

Avg: $146

LISA CATAPANO-FRIEDMAN M.D.

Psychiatry

1,190

$130K

155
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $146

DONNA KILEY M.D.

Psychiatry

1,204

$170K

96
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$141
Average prescription price

Avg: $146

ELIZABETH PIERSON M.D.

Psychiatry

1,211

$116K

73
19 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$96
Average prescription price

Avg: $146

LINDA ZAMVIL MD

Psychiatry

1,217

$262K

107
13 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$215
Average prescription price

Avg: $146

JUSTIN KNAPP M.D.

Psychiatry

1,257

$123K

168
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$98
Average prescription price

Avg: $146

RAY ABNEY MD

Psychiatry

1,274

$148K

134
32 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$116
Average prescription price

Avg: $146

TIMOTHY LAROSA MD

Psychiatry

1,328

$199K

55
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$150
Average prescription price

Avg: $146

ELLIOT KAUFMAN MD

Psychiatry

1,357

$146K

81
0 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$107
Average prescription price

Avg: $146

ROBERTA BENNETT M.D.

Psychiatry

1,436

$195K

42
0 are 65+

36%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$136
Average prescription price

Avg: $146

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank